Related Experiment Video
Updated: Jan 7, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Association between triglyceride-glucose derived indices with cardiometabolic multimorbidity: Findings from the
Yi Liu1,2,3, Dongze Li1,2,3, Jing Yu1,2,3
1West China School of Nursing, Sichuan University/Department of Emergency Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Background:
Cardiometabolic multimorbidity (CMM), characterized by the co-occurrence of diabetes mellitus (DM), stroke, and coronary heart disease (CHD), imposes substantial global health burden owing to its association with elevated mortality risk, reduced functional capacity, and increased healthcare costs. Despite its clinical importance, the value of insulin resistance (IR) and its surrogates, particularly triglyceride-glucose (TyG) indices combined with anthropometric measures, in predicting CMM remains underexplored.
Methods:
In this study, we aimed to quantify the association between TyG-derived indices and incident CMM. For this purpose, we conducted a multivariate logistic regression analysis of data of the Atherosclerosis Risk in Communities (ARIC) study, deriving adjusted odds ratios (ORs) and 95% confidence intervals (CIs). Nonlinear associations were investigated using restricted cubic spline modeling and diagnostic accuracy was evaluated using area under the curve (AUC) values from receiver operating characteristic (ROC) analyses.
Results:
Nonlinear relationships were observed between TyG-body mass index (TyG-BMI) and TyG-waist-to-height ratio, whereas TyG and TyG-waist circumference exhibited linear trends. TyG-BMI demonstrated the strongest association with CMM risk, showing a 1.61-fold increase per standard deviation (adjusted OR: 1.61; 95% CI: 1.48-1.73) and a 5.67-fold higher risk in the highest versus the lowest quartiles. Predictive performance analysis revealed that TyG-BMI was the most discriminative marker (AUC: 0.684; 95% CI: 0.664-0.705).
Conclusions:
TyG-BMI emerged as a robust predictor of CMM risk, highlighting the synergistic effects of IR and adiposity. The nonlinear risk escalation suggests threshold-dependent mechanisms, emphasizing its utility in early risk stratification.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Related Concept Videos
Coronary Artery Disease I: Introduction
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Atherosclerosis III: Management
Obesity
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests